CX DAILY

CX Daily: Chinese Medicine Injections Face Rigorous Regulation for the First Time

Published: Dec. 9, 2025 9:00 a.m. GMT+8

00:00

00:00/00:00

Listen to this article 1x

TOP STORIES

Cover Story: Chinese Medicine Injections Face Rigorous Regulation for the First Time

The deaths first surfaced in a scattering of headlines: a toddler in Heilongjiang, a patient in Anhui, clusters of severe allergic reactions in hospitals across China. Each case shared one unsettling detail — the drug involved was a traditional Chinese medicine injection, a class of products used for decades, trusted by millions and supported by enormous sales.

FINANCE & ECONOMY

China Opens New Insurance Path for High-Cost Drugs

Register to read this article for free.

Register

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Scores Dead, Hundreds Missing in Hong Kong Inferno

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

Caixin Deep Dive: Chinese Local Governments Risk Replicating Mistakes of LGFVs

00:00

00:00/00:00

MOST POPULAR

1: Wingtech Rebuts Nexperia Claims as Control Fight Threatens Global Chip Supply

2: France to Receive New Panda Pair Under Renewed 10-Year Deal With China

3: Cover Story: Chinese Medicine Injections Face Rigorous Regulation for the First Time

4: China Flu Cases Surge to Highest Level Since 2022

5: BYD Overhauls Payment System as China Tightens Oversight

SPONSORED

OR